Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2009
10/15/2009WO2009125853A1 Homocysteine synthase inhibitor
10/15/2009WO2009125434A2 Oxime derivatives
10/15/2009WO2009125366A1 Substituted 2-phenyl-pyridine derivatives
10/15/2009WO2009125231A2 Anti-atheroma vaccine
10/15/2009WO2009125168A1 New combination for use in the treatment of inflammatory disorders
10/15/2009WO2009125029A1 Method for preparing amorphous combinations of angiotensin ii receptor antagonists and diuretics
10/15/2009WO2009124973A1 Inhibitors of stim1 for the treatment of cardiovascular disorders
10/15/2009WO2009124962A2 Sulfonamides
10/15/2009WO2009124940A1 Ivabradine hydrobromide
10/15/2009WO2009124636A1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
10/15/2009WO2009124552A2 Use of a combination of hypothermia inducing drugs
10/15/2009WO2009124391A1 Anti-angiogenesis, anticancer proliferation properties of lymphocytic-derived microparticles
10/15/2009WO2009093934A3 Substituted 3-sulphonyl-[1,2,3]triazolo [1,5-a]pyrimidines-antagonists of serotonin 5-ht6 receptors and methods for the production thereof
10/15/2009WO2009091542A9 Antibodies to bufadienolides prevent inhbition of na/katpase and prolong survival in shock
10/15/2009WO2009086123A8 Imidazo [1,2-a] pyridine compounds
10/15/2009WO2009065920A3 Compounds
10/15/2009WO2009043465A3 Use of beta-endorphin as a therapeutic agent
10/15/2009WO2009033790A3 Use of a peptide as a therapeutic agent
10/15/2009WO2009033780A3 Use of growth hormone-releasing factor and/or k237 as a therapeutic agents
10/15/2009WO2009033768A3 Use of a peptide as a therapeutic agent
10/15/2009US20090259302 Coating comprising poly (ethylene glycol)-poly (lactide-glycolide-caprolactone) interpenetrating network
10/15/2009US20090259051 Carvedilol phosphate sesquihydrate
10/15/2009US20090258936 Cxcr2 inhibitors
10/15/2009US20090258919 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and / or congestive heart failure
10/15/2009US20090258907 Compounds useful as inhibitors of rock kinases
10/15/2009US20090258906 Cxcr2 antagonists
10/15/2009US20090258901 Ligands for monoamine receptors and transporters, and methods of use thereof
10/15/2009US20090258885 Diphenylmethane Derivatives as Inhibitors of Leukotriene Biosynthesis
10/15/2009US20090258884 Substituted amides
10/15/2009US20090258868 Heterocyclic aspartyl protease inhibitors
10/15/2009US20090258860 Xanthine derivatives for the treatment of vascular depression
10/15/2009US20090258851 Diaryl substituted alkanes
10/15/2009US20090258819 Reagents and Methods for Smooth Muscle Therapies
10/15/2009US20090258421 Embryonic stem cells and neural progenitor cells derived therefrom
10/15/2009US20090258081 New plant derived seed extract rich in essentially fatty acids derived from salvia hispanica l. seed: composition of matter, manufacturing process and use
10/15/2009US20090258063 Transdermal patch
10/15/2009US20090258055 Heparin Prodrugs and Drug Delivery Stents Formed Therefrom
10/15/2009US20090258003 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
10/15/2009US20090257998 Method for treating heart attacks, strokes and diabetic crisis by utilizing modified virus virions to insert necessary protein molecules and vital nutrients into targeted cells
10/15/2009US20090257981 Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same
10/15/2009US20090257953 Novel fluorine-18 labeled rhodamine derivatives for myocardial perfusion imaging with positron emission tomography
10/15/2009US20090256006 Generation of therapeutic microfoam
10/15/2009DE102008017853A1 Thienopyrimidine Thienopyrimidines
10/15/2009DE102008015607A1 New boswellic acid derivatives are microsomal prostaglandin E-1 synthesis inhibitors, useful to treat e.g. rheumatoid arthritis, inflammatory bowel disease, asthma, feverish and painful conditions, cancers, emphysema and multiple sclerosis
10/15/2009CA2758213A1 Anti-atheroma vaccine
10/15/2009CA2725425A1 Homocysteine synthase inhibitor
10/15/2009CA2721080A1 Estrogenic extracts of anemarrhena asphodeloides bge. from the liliaceae family and uses thereof
10/15/2009CA2721025A1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
10/15/2009CA2720887A1 Inhibitors of stim1 for the treatment of cardiovascular disorders
10/15/2009CA2720614A1 Neutralization of gm-csf for the treatment of heart failure
10/15/2009CA2720547A1 New combination for use in the treatment of inflammatory disorders
10/15/2009CA2720530A1 Sulfonamides
10/15/2009CA2719636A1 Substituted 2-phenyl-pyridine derivatives
10/15/2009CA2719376A1 2h-benzo[b][1,4]oxazin-3(4h)-one derivatives for use as stearoyl coa desaturase inhibitors
10/14/2009EP2108655A1 Immune-modulating peptide
10/14/2009EP2108370A1 Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
10/14/2009EP2107907A1 New combination for use in the treatment of inflammatory disorders
10/14/2009EP1838670B1 Process for the preparation of carvedilol and its enantiomers
10/14/2009EP1755604B1 Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin
10/14/2009EP1622897B1 Inhibitors of phosphatidylinositol 3-kinase
10/14/2009EP1554572B1 Compositions and methods for modulating blood-brain barrier transport
10/14/2009EP1483269B1 Racemization and enantiomer separation of clopidogrel
10/14/2009EP1461337B1 Pyrido¬2,1-a isoquinoline derivatives as dpp-iv inhibitors
10/14/2009EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/14/2009EP1337527B1 Indolylmaleimide derivatives as protein kinase c inhibitors
10/14/2009EP1153129B1 Method of treating restenosis by antisense targeting of c-myc
10/14/2009CN101558063A Compositions of azimilide dihydrochloride
10/14/2009CN101558061A Process for preparing a crystalline form of candesartan cilexetil
10/14/2009CN101557751A Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
10/14/2009CN101555235A Manufacture process of piperazine ferulate
10/14/2009CN101555199A Branched chain fatty acid compound and derivative thereof for preventing and curing ischemical reperfusion injury
10/14/2009CN101554475A Use of secondary heme short peptide compound in preparation of anti-cerebral ischemia drugs
10/14/2009CN101554471A Traditional Chinese medicine preparation for treating myocardial infarction
10/14/2009CN101554470A Traditional Chinese medicine for treating tachycardia
10/14/2009CN101554466A Drug for treating coronary heart disease
10/14/2009CN101554463A Drug for treating gynecologic and andrological diseases and preparation method thereof
10/14/2009CN101554443A Traditional Chinese medicine for treating angina
10/14/2009CN101554441A Traditional Chinese medicine for treating coronary heart disease
10/14/2009CN101554439A Traditional Chinese medicine preparation for preventing cerebral arteriosclerosis
10/14/2009CN101554438A Traditional Chinese medicine for curing hemorrhoids
10/14/2009CN101554434A Traditional Chinese medicine for treating clinical hypertension
10/14/2009CN101554432A Fumigating and washing medicine for curing hemorrhoids
10/14/2009CN101554412A Traditional Chinese medicine for treating atrial fibrillation
10/14/2009CN101554409A Long pepper alkaloid and preparation method, preparation and application thereof
10/14/2009CN101554405A Selfheal, mulberry leaf and wild chrysanthemum dripping pills and preparation method thereof
10/14/2009CN101554394A Process for extracting total flavonoid from canola plant bee pollen
10/14/2009CN101554393A Ultrasonic extracting process of flavonoid materials in canola plant bee pollen
10/14/2009CN101554381A Candesartan cilexetil hydrochlorothiazide double-layer tablets and preparation mehtod thereof
10/14/2009CN101554375A Pharmaceutical composition containing clopidogrel and carbazochrome sodium sulfonate
10/14/2009CN101554370A Syringin for injection, preparation method and application thereof
10/14/2009CN101554362A Composition of natural product and preparation thereof
10/14/2009CN101554210A A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
10/14/2009CN100549008C Substituted oxazolidinones and their use in the field of blood coagulation
10/14/2009CN100549005C Optically active dihydropyridine derivative
10/14/2009CN100548998C Cinepazide maleate crystal form and its preparation method
10/14/2009CN100548996C 5-phenylthiazole derivatives and its use for preparing medicine
10/14/2009CN100548993C Salts of valsartan
10/14/2009CN100548977C Prostaglandin-like compound and its uses for treatment of external secretion disorders
10/14/2009CN100548960C Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
10/14/2009CN100548383C Method and compositions for prevention or treatment of cancer
1 ... 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 ... 1595